The DOI matches its Crossref record.
P1–160: Olfactory identification as a potential marker of presymptomatic Alzheimer's disease
Abstract
Several studies suggest that olfactory dysfunction is an early symptom of Alzheimer's disease (AD). The olfactory bulb and entorhinal cortex are among the first brain structures affected in AD pathology. Therefore, changes in olfactory function may serve as a marker for the progress of pre-symptomatic AD. We have begun a program to explore olfaction as an endpoint for trials of interventions that may arrest or delay pre-symptomatic AD, and thus serve as potential agents for prevention of AD dementia. As a first step in this research we examined (baseline) olfactory abilities in relation to cognitive functions in a group of older dementia-free subjects at risk of AD. 73 adults aged 55 and older, with a first degree family history of AD, were enrolled in a pilot clinical trial of an agent with potential for mitigation of pre-symptomatic AD progression. At baseline, these persons were evaluated cognitively using the Repeatable Battery for the Assessment of Neuropsychological Status (RBANS), and their sense of smell was evaluated using the University of Pennsylvania Smell Identification Test (UPSIT). Here we report the association of these two measures. 62 % of the sample were female. Mean age was 65.6 ± s.d. 5.0 yrs, and mean education 15.4 ± s.d. 3.3 years. Baseline UPSIT score was significantly associated with score on the RBANS immediate memory sub-scale (Pearson r = 0.350, P < 0.002), and showed a trend toward association with overall RBANS score (r = 0.229, P = 0.051). Participants will now be followed to observe change over time in UPSIT and/or RBANS scores, as well as several imaging and other potential biomarkers.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
The case for rejecting the amyloid cascade hypothesis
Herrup, K. (2015) · Nature Neuroscience · doi:10.1038/nn.4017 · Cited by 768
Sleep, Cognitive impairment, and Alzheimer's disease: a systematic review and meta-analysis
Bubu, O. M., Brannick, M., Mortimer, J., Umasabor-Bubu, O., Sebastião, Y. V., Wen, Y., Schwartz, S., Borenstein, A. R., Wu, Y., Morgan, D., et al. (2017) · Sleep · doi:10.1093/sleep/zsw032 · Cited by 673
The Alzheimer’s Disease Clinical Spectrum
Atri, A. (2019) · Medical Clinics of North America · doi:10.1016/j.mcna.2018.10.009 · Cited by 623
The epigenetics of aging and neurodegeneration
Lardenoije, R., Iatrou, A., Kenis, G., Kompotis, K., Steinbusch, H. W. M., Mastroeni, D., Coleman, P., Lemere, C. A., Hof, P. R., van den Hove, D. L. A., et al. (2015) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2015.05.002 · Cited by 381
Cheng, K. K., Chan, P. S., Fan, S., Kwan, S. M., Yeung, K. L., Wáng, Y.-X. J., Chow, A. H. L., Wu, E. X., & Baum, L. (2015) · Biomaterials · doi:10.1016/j.biomaterials.2014.12.005 · Cited by 293
Metadata
- Authors
- Lafaille‐Magnan, M., Breitner, J., Etienne, P., Poirier, J., Fontaine, D., Rosa‐Neto, P., & Rajah, N.
- Venue
- Alzheimer's & Dementia
- Publisher
- Wiley
- Published
- 2013-07
- Volume
- 9
- Issue
- 4S_Part_5
- ISSN
- 1552-5260 (ISSN-L)
- 1552-5279
- OpenAlex
- W1977308814
- Cited by
- 172
- References
- 0
- FWCI
- 17.81
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: P1–160: Olfactory identification as a potential marker of presymptomatic Alzheimer's disease. https://app.cochat.ai/papers/10.1016/j.jalz.2013.05.383
- The paper
- Lafaille‐Magnan, M., Breitner, J., Etienne, P., Poirier, J., Fontaine, D., Rosa‐Neto, P., & Rajah, N. (2013). P1–160: Olfactory identification as a potential marker of presymptomatic Alzheimer's disease. Alzheimer's & Dementia. https://doi.org/10.1016/j.jalz.2013.05.383
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.